>Mercado de rellenos dérmicos de América del Norte, por tipo de producto (rellenos dérmicos biodegradables, rellenos dérmicos no biodegradables), tipo de material (rellenos dérmicos naturales, rellenos dérmicos sintéticos), aplicación (lifting facial, rinoplastia, cirugía reconstructiva , corrección de líneas faciales, realce de labios, flacidez de la piel, depresión de las mejillas, suavizado de la piel, odontología, restauración estética, relleno de labios, tratamiento de cicatrices, aumento de mentón, tratamiento de lipoatrofia, rejuvenecimiento del lóbulo de la oreja y otros), tipo de fármaco (de marca, genérico), usuario final (clínicas de dermatología, centros quirúrgicos ambulatorios, hospitales, institutos de investigación académica y otros), canal de distribución (licitación directa, farmacias, farmacias minoristas, farmacias en línea y otros) - Tendencias de la industria y pronóstico hasta 2029.
Análisis y perspectivas del mercado de rellenos dérmicos en América del Norte
Los rellenos dérmicos son sustancias gelatinosas que se inyectan debajo de la piel para restaurar el volumen perdido, a menudo las arrugas y suavizar las líneas o mejorar los contornos faciales. El uso de rellenos dérmicos ha crecido rápidamente en los últimos años debido a las diversas ofertas para mejorar la estética y rejuvenecer las mejoras que antes solo se podían lograr con cirugías. Estos se están volviendo muy populares para los métodos de rejuvenecimiento facial. Al ser un relleno dérmico mínimamente invasivo, se muestran resultados instantáneos en las terapias cosméticas de reemplazo de volumen. Estos dispositivos brindan volumen al rostro, realzan y mejoran la calidad de la piel. Se utilizan varios métodos, como las inyecciones, para el aumento. Estos rellenos pueden dar labios más llenos y voluminosos con fines estéticos. Hay muchos tipos de rellenos dérmicos que se pueden inyectar en los labios y alrededor de la boca que mantienen el volumen de los labios de forma temporal o permanente según el tipo de producto utilizado. Algunos actores del mercado están involucrados en los productos nuevos e innovadores, y sus productos están en desarrollo. Durante los últimos años, se han desarrollado nuevos e innovadores productos de relleno dérmico para aumentar el crecimiento del mercado de rellenos dérmicos, y los actores del mercado están mejorando su cartera de productos. Muchos actores del mercado están involucrados en la fabricación de rellenos dérmicos con innovaciones que allanan el camino para el crecimiento del mercado.
Data Bridge Market Research analiza que se espera que el mercado de rellenos dérmicos alcance un valor de USD 5.714,57 millones para 2029, con una CAGR del 11,4% durante el período de pronóstico 2022-2029.
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2022 a 2029 |
|
Año base |
2021 |
|
Año histórico |
2020 (Personalizable para 2019-2014) |
|
Unidades cuantitativas |
Ingresos en millones de USD, volúmenes en unidades, precios en USD |
|
Segmentos cubiertos |
By Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others) |
|
Countries Covered |
U.S., Canada, Mexico in North America |
|
Market Players Covered |
Allergan (A Subsidiary of Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (A subsidiary of HUONS GLOBAL),Galderma Laboratories, L.P., Merz North America, Inc. (A Subsidiary of Merz Pharma),Croma-Pharma GmbH, Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS,among others. |
Market Definition
Dermal fillers are substances designed to be injected into the skin to add fullness and volume. The substances used in dermal fillers include Calcium hydroxylapatite (a mineral-like compound found in bones), Hyaluronic acid, Polyalkylimide, Polylactic acid, Polymethyl-methacrylate microspheres (PMMA). Dermal fillers can be classified based on several criteria, including the deep dermis, depth of implantation (a superficial midterms and upper, and subcutaneous levels); longevity of correction (temporary and permanent); allergenicity, the composition of the agent (allografts, semi/fully synthetic, xenografts, or autologous); and stimulatory behavior (physiologic processes of endogenous tissue proliferation) versus replacement fillers (space-replacing effect).
Temporary dermal fillers such as HA and collagen are biodegradable and last from 4 to 9 months. The prospective side effects and dissatisfaction are also short-lived. Therefore, temporary fillers are always used as the first line of therapy to save long-lasting fillers for future patient visits.
Permanent fillers are essentially used in the alteration of deep lines and furrows of the skin, which are beyond normal facial wrinkles. They are considered an excellent option in facial rejuvenation, especially in HIV lipodystrophy. Polymethyl methacrylate (PMMA) is mostly used for safe, effective, and long-lasting effects.
Dermal Fillers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Rising prevalence of minimally-invasive procedures
The use of minimally invasive procedures has been shifted as compared to traditional methods for aesthetic and cosmetics surgeries techniques including laser and other energy-based devices. For the use of surgical or non-surgical procedures, specially-designed instruments have been developed for minimally used procedures. These anti-aging devices help in reducing the visual effects of skin aging by revitalizing and tightening the skin, which gives a younger look.
Minimally-invasive surgery is a procedure conducted with the assistance of a scope of viewing and specially-equipped surgical instruments. It targets facial irregularities including wrinkles and fine lines and decreases volume and contour and unwanted fat. These have essentially no risk of serious adverse events as the procedures allow no cuts or minimal cuts with lesser recovery time which is increasing the demand for use of minimally invasive procedures. Minimally-invasive energy-based treatments for skin tightening, wrinkle reduction, face contouring and skin rejuvenation have a high demand in the world. Other reasons driving the demand for these procedures are increasing aging people and rising requirement of healthcare facilities which can further result in decrease in burden on healthcare facilities.
With rising technological advancements and communications, people are more aware of aesthetic devices and procedures that are well performed in the healthcare field, impacting the adoption of minimally invasive procedures positively in the upcoming era. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the dermal fillers market.
- Increasing geriatric population
The geriatric population is expanding for longer life span and is reported to have increasing skin ageing conditions. The speed of aging population is increasing exponentially in the world whereas European countries have certain cultural, social and economic characteristics in common with similar aspirations. As people start aging, increase in appearance to appear as younger raises which ultimately develops interest in utilization of aesthetic procedures.
Rising improving healthcare delivery and its scenario in the Middle Eastern countries among the percentage of elderly people have resulted in better patients’ outcome services.
Opportunities
- Increasing funding activities for aesthetic research
Plastic surgery, unwanted hair removal, skin tightening, anti-aging, excess fat removal, body contouring and several other cosmetic procedures that are to be performed through minimally invasive procedures follow under medical aesthetic devices that are used for increased appearances, beautification and other improvement part of body. Various foundations and government organizations are investing a large amount in aesthetic research.
- Advancement in the new dermal fillers
Dermal fillers are in the form of gel-like substances, which are injected beneath the skin to restore the lost volume, soften creases and smooth lines. It is also used to enhance facial contours; each year more than 1 million people prefer this popular facial transformation treatment to restore the wrinkles and appearance of facial lines. Dermal fillers are an effective treatment way to look younger without downtime or surgery. Dermal fillers drug is injected into the skin which helps in filling the facial wrinkles. There are different types of dermal fillers drugs available, the most common types are Calcium hydroxylapatite, Hyaluronic acid, Polyalkylimide, Polylactic acid and others. Advancement in the dermal fillers brands will help to boost the demand of the market.
Restrains/ Challenges
- High cost of aesthetic procedures
Cost is always a consideration in the elective procedure. The cost of dermal filler is depending on the type of filler and the amount is used in the treatment. Also, the treatment cost is based on the qualifications and expertise of the person performing the dermal fillers treatment. The cosmetic treatment of dermal filler is a safe outpatient procedure and it is a very popular treatment for restoring lost volume and treating some signs of aging, but the high cost of the procedures is expected to hamper the demand of the market
- Lack of skilled professionals
Aesthetic treatment procedures are of different type’s laser-based technology, energy-based technology and intense pulse light among others. All such techniques need qualified interpersonal skills in order to carry out effective treatment.
Moreover, rapid technological advancement in this field also lead to lack of skilled professionals. Lack of skilled professionals pose major challenge while device handling and carrying out surgical procedures.
Recent Developments
- In April 2022, Sinclair Pharma announced the company has received European CE mark for Perfectha Lidocaine in the treatment of wrinkle correction, facial contouring, and volume restoration. This CE certificate results in launch of Perfectha Lidocaine in the UK and all major European markets.
Dermal Fillers Market Segmentation
El mercado de rellenos dérmicos está segmentado en función del tipo de producto, tipo de material, aplicación, tipo de fármaco, usuario final y canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus principales áreas de aplicación y la diferencia en sus mercados objetivo.
Por tipo de producto
- Rellenos dérmicos biodegradables
- Rellenos dérmicos no biodegradables
Según el tipo de producto, el mercado de rellenos dérmicos se segmenta en rellenos dérmicos biodegradables y rellenos dérmicos no biodegradables.
Por tipo de material
- Rellenos dérmicos naturales
- Rellenos dérmicos sintéticos
Según el tipo de material, el mercado está segmentado en rellenos dérmicos naturales y rellenos dérmicos sintéticos.
Por aplicación
- Estiramiento facial
- Rinoplastia
- Cirugía reconstructiva
- Corrección de líneas faciales
- Aumento de labios
- Piel flácida
- Depresión de la mejilla
- Suavizado de la piel
- Odontología
- Restauración estética
- Labios color ciruela
- Tratamiento de cicatrices
- Aumento de mentón
- Tratamiento de la lipoatrofia
- Rejuvenecimiento del lóbulo de la oreja
- Otros
Sobre la base de la aplicación, el mercado está segmentado en estiramiento facial, rinoplastia, cirugía reconstructiva, corrección de líneas faciales, aumento de labios, flacidez de la piel, depresión de las mejillas, suavizado de la piel, odontología, restauración estética, tratamiento de cicatrices, aumento de mentón, tratamiento de lipoatrofia, rejuvenecimiento del lóbulo de la oreja y otros.
Por tipo de fármaco
- De marca
- Genérico
Según el tipo de medicamento, el mercado se segmenta en de marca y genéricos.
Por el usuario final
- Clínicas de Dermatología
- Hospitales
- Centros de cirugía ambulatoria
- Institutos de investigación académica
- Otros
Según el usuario final, el mercado está segmentado en clínicas de dermatología, centros quirúrgicos ambulatorios, hospitales, institutos de investigación académica y otros.
Por canal de distribución
- Licitación directa
- Farmacias
- Farmacia minorista
- Farmacia en línea
- Otros
Sobre la base del canal de distribución, el mercado está segmentado en licitación directa, farmacias, farmacias minoristas, farmacias en línea y otros.
Análisis y perspectivas regionales del mercado de rellenos dérmicos
Se analiza el mercado de rellenos dérmicos y se proporcionan información y tendencias del tamaño del mercado por país, por tipo de producto, por tipo de material, por aplicación, por tipo de fármaco, por usuario final y por canal de distribución como se menciona anteriormente.
Los países cubiertos en el informe del mercado de rellenos dérmicos son Estados Unidos, Canadá y México en América del Norte.
Se espera que Estados Unidos domine el mercado debido al uso exponencial de la cirugía mínimamente invasiva para tratamientos de la piel en el país.
La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación del mercado que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas arriba y aguas abajo, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales al proporcionar un análisis de pronóstico de los datos del país.
Análisis del panorama competitivo y de la cuota de mercado de los rellenos dérmicos
El panorama competitivo del mercado de rellenos dérmicos proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en el mercado de rellenos dérmicos.
Algunos de los principales actores que operan en el mercado son Allergan (una subsidiaria de Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (una subsidiaria de HUONS GLOBAL), Galderma Laboratories, LP, Merz North America, Inc. (una subsidiaria de Merz Pharma), Croma-Pharma GmbH, Sinclair Pharma (una subsidiaria de Huadong Medicine Co., Ltd.), Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS, entre otros.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DERMAL FILLERS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 EPIDEMIOLOGY PROCEDURES PER COUNTRY
5 REGULATIONS OF NORTH AMERICA DERMAL FILLERS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES
6.1.2 INCREASING GERIATRIC POPULATION
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN DERMAL FILLERS
6.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AESTHETIC PROCEDURES
6.2.2 ESCALATING PRODUCT RECALL
6.2.3 FDA GUIDELINES FOR ADVANCED DERMAL FILLER INJECTORS
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE
6.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH
6.3.3 ADVANCEMENT IN THE NEW DERMAL FILLERS
6.3.4 INCREASING COMPENSATION AND ACCIDENTAL CLAIMS FOR DERMAL FILLER
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 AVAILABILITY OF ALTERNATIVES
7 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 BIODEGRADABLE DERMAL FILLERS
7.2.1 TEMPORARY BIODEGRADABLE
7.2.2 SEMI-PERMANENT BIODEGRADABLE
7.3 NON-BIODEGRADABLE DERMAL FILLERS
8 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE
8.1 OVERVIEW
8.2 NATURAL DERMAL FILLERS
8.2.1 HYALURONIC ACID
8.2.1.1 BY TYPE
8.2.1.1.1 MONOPHASIC FILLERS
8.2.1.2 BY TYPE
8.2.1.2.1 MONODENSIFIED
8.2.1.2.2 POLYDENSIFIED
8.2.1.2.3 BIPHASIC FILLERS
8.2.1.3 BY MATERIAL TYPE
8.2.1.3.1 SINGLE-PHASE
8.2.1.3.2 DUPLEX-PHASE
8.2.1.4 BY APPLICATION
8.2.1.4.1 FACE LIFT
8.2.1.4.2 RHINOPLASTY
8.2.1.4.3 RECONSTRUCTIVE SURGERY
8.2.1.4.4 FACIAL LINE CORRECTION
8.2.1.4.5 LIP ENHANCEMENT
8.2.1.4.6 SAGGING SKIN
8.2.1.4.7 CHEEK DEPRESSION
8.2.1.4.8 SKIN SMOOTHING
8.2.1.4.9 DENTISTRY
8.2.1.4.10 AESTHETIC RESTORATION
8.2.1.4.11 SCAR TREATMENT
8.2.1.4.12 CHIN AUGMENTATION
8.2.1.4.13 LIPOATROPHY TREATMENT
8.2.1.4.14 EARLOBE REJUVENATION
8.2.1.4.15 OTHERS
8.2.2 FAT
8.2.2.1 BY APPLICATION
8.2.2.1.1 FACE LIFT
8.2.2.1.2 RHINOPLASTY
8.2.2.1.3 RECONSTRUCTIVE SURGERY
8.2.2.1.4 FACIAL LINE CORRECTION
8.2.2.1.5 LIP ENHANCEMENT
8.2.2.1.6 SAGGING SKIN
8.2.2.1.7 CHEEK DEPRESSION
8.2.2.1.8 SKIN SMOOTHING
8.2.2.1.9 DENTISTRY
8.2.2.1.10 AESTHETIC RESTORATION
8.2.2.1.11 SCAR TREATMENT
8.2.2.1.12 CHIN AUGMENTATION
8.2.2.1.13 LIPOATROPHY TREATMENT
8.2.2.1.14 EARLOBE REJUVENATION
8.2.2.1.15 OTHERS
8.2.3 COLLAGEN
8.2.3.1 BY APPLICATION
8.2.3.1.1 FACE LIFT
8.2.3.1.2 RHINOPLASTY
8.2.3.1.3 RECONSTRUCTIVE SURGERY
8.2.3.1.4 FACIAL LINE CORRECTION
8.2.3.1.5 LIP ENHANCEMENT
8.2.3.1.6 SAGGING SKIN
8.2.3.1.7 CHEEK DEPRESSION
8.2.3.1.8 SKIN SMOOTHING
8.2.3.1.9 DENTISTRY
8.2.3.1.10 AESTHETIC RESTORATION
8.2.3.1.11 SCAR TREATMENT
8.2.3.1.12 CHIN AUGMENTATION
8.2.3.1.13 LIPOATROPHY TREATMENT
8.2.3.1.14 EARLOBE REJUVENATION
8.2.3.1.15 OTHERS
8.2.4 OTHERS
8.3 SYNTHETIC DERMAL FILLERS
8.3.1 POLY-L-LACTIC ACID
8.3.1.1 BY APPLICATION
8.3.1.1.1 FACE LIFT
8.3.1.1.2 RHINOPLASTY
8.3.1.1.3 RECONSTRUCTIVE SURGERY
8.3.1.1.4 FACIAL LINE CORRECTION
8.3.1.1.5 LIP ENHANCEMENT
8.3.1.1.6 SAGGING SKIN
8.3.1.1.7 CHEEK DEPRESSION
8.3.1.1.8 SKIN SMOOTHING
8.3.1.1.9 DENTISTRY
8.3.1.1.10 AESTHETIC RESTORATION
8.3.1.1.11 SCAR TREATMENT
8.3.1.1.12 CHIN AUGMENTATION
8.3.1.1.13 LIPOATROPHY TREATMENT
8.3.1.1.14 EARLOBE REJUVENATION
8.3.1.1.15 OTHERS
8.3.2 CALCIUM HYDROXYLAPATITE
8.3.2.1 BY APPLICATION
8.3.2.1.1 FACE LIFT
8.3.2.1.2 RHINOPLASTY
8.3.2.1.3 RECONSTRUCTIVE SURGERY
8.3.2.1.4 FACIAL LINE CORRECTION
8.3.2.1.5 LIP ENHANCEMENT
8.3.2.1.6 SAGGING SKIN
8.3.2.1.7 CHEEK DEPRESSION
8.3.2.1.8 SKIN SMOOTHING
8.3.2.1.9 DENTISTRY
8.3.2.1.10 AESTHETIC RESTORATION
8.3.2.1.11 SCAR TREATMENT
8.3.2.1.12 CHIN AUGMENTATION
8.3.2.1.13 LIPOATROPHY TREATMENT
8.3.2.1.14 EARLOBE REJUVENATION
8.3.2.1.15 OTHERS
8.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
8.3.3.1 BY APPLICATION
8.3.3.1.1 FACE LIFT
8.3.3.1.2 RHINOPLASTY
8.3.3.1.3 RECONSTRUCTIVE SURGERY
8.3.3.1.4 FACIAL LINE CORRECTION
8.3.3.1.5 LIP ENHANCEMENT
8.3.3.1.6 SAGGING SKIN
8.3.3.1.7 CHEEK DEPRESSION
8.3.3.1.8 SKIN SMOOTHING
8.3.3.1.9 DENTISTRY
8.3.3.1.10 AESTHETIC RESTORATION
8.3.3.1.11 SCAR TREATMENT
8.3.3.1.12 CHIN AUGMENTATION
8.3.3.1.13 LIPOATROPHY TREATMENT
8.3.3.1.14 EARLOBE REJUVENATION
8.3.3.1.15 OTHERS
8.3.4 POLYALKYLIMIDE
8.3.4.1 BY APPLICATION
8.3.4.1.1 FACE LIFT
8.3.4.1.2 RHINOPLASTY
8.3.4.1.3 RECONSTRUCTIVE SURGERY
8.3.4.1.4 FACIAL LINE CORRECTION
8.3.4.1.5 LIP ENHANCEMENT
8.3.4.1.6 SAGGING SKIN
8.3.4.1.7 CHEEK DEPRESSION
8.3.4.1.8 SKIN SMOOTHING
8.3.4.1.9 DENTISTRY
8.3.4.1.10 AESTHETIC RESTORATION
8.3.4.1.11 SCAR TREATMENT
8.3.4.1.12 CHIN AUGMENTATION
8.3.4.1.13 LIPOATROPHY TREATMENT
8.3.4.1.14 EARLOBE REJUVENATION
8.3.4.1.15 OTHERS
8.3.5 OTHERS
9 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FACE LIFT
9.2.1 DEEP PLANE/SMAS FACE
9.2.2 MINI FACE LIFT
9.2.3 MID-FACE LIFT
9.2.4 JAW LINE
9.2.5 CUTANEOUS LIFT
9.2.6 TEMPORAL OR BROW LIFT
9.2.7 LIQUID FACE LIFT
9.2.8 OTHERS
9.2.8.1 JUVEDERM
9.2.8.2 RESTYLANE
9.2.8.3 SCULPTRA
9.2.8.4 DYSPORT
9.2.8.5 OTHERS
9.3 RHINOPLASTY
9.3.1 JUVEDERM
9.3.1.1 JUVEDERM XC
9.3.1.2 JUVEDERM ULTRA XC
9.3.1.3 JUVEDERM VOLUMA
9.3.1.4 JUVEDERM VOLBELLA
9.3.1.5 JUVEDERM VOLLURE XC
9.3.2 RESTYLANE
9.3.2.1 RESTYLANE SILK
9.3.2.2 RESTYLANE LYFT
9.3.2.3 RESTYLANE REFYNE
9.3.2.4 RESTYLANE DEFYNE
9.3.2.5 RESTYLANE-L
9.3.3 OTHERS
9.4 RECONSTRUCTIVE SURGERY
9.4.1 JUVEDERM
9.4.2 RESTYLANE
9.4.3 OTHERS
9.5 FACIAL LINE CORRECTION
9.5.1 DYNAMIC WRINKLES
9.5.2 STATIC WRINKLES
9.5.3 WRINKLE FOLDS
9.5.3.1 FOREHEAD LINES
9.5.3.2 WORRY LINES
9.5.3.3 BUNNIES
9.5.3.4 CROW’S FEET
9.5.3.5 LAUGH LINES
9.5.3.6 LIP LINES
9.5.3.7 MARIONETTE LINES
9.5.3.8 OTHERS
9.5.3.8.1 JUVEDERM
9.5.3.8.2 RESTYLANE
9.5.3.8.3 RADIESSE
9.5.3.8.4 BELOTERO
9.5.3.8.5 OTHERS
9.6 LIP ENHANCEMENT
9.6.1 JUVEDERM
9.6.1.1 JUVÉDERM XC
9.6.1.2 JUVÉDERM ULTRA XC
9.6.1.3 JUVÉDERM VOLUMA
9.6.1.4 JUVÉDERM VOLBELLA
9.6.1.5 JUVÉDERM VOLLURE XC
9.6.2 RESTYLANE
9.6.2.1 RESTYLANE SILK
9.6.2.2 RESTYLANE LYFT
9.6.2.3 RESTYLANE REFYNE
9.6.2.4 RESTYLANE DEFYNE
9.6.2.5 RESTYLANE-L
9.6.3 BELOTERO BALANCE
9.6.4 REVANESSE VERSA
9.6.5 HYLAFORM
9.6.6 PREVELLE SILK
9.6.7 OTHERS
9.7 SAGGING SKIN
9.7.1 JUVEDERM
9.7.2 RESTYLANE
9.7.3 BELOTERO
9.7.4 OTHERS
9.8 CHEEK DEPRESSION
9.8.1 JUVEDERM VOLUMA
9.8.2 RESTYLANE-LYFT
9.8.3 SCULPTRA
9.8.4 RADIESSE
9.8.5 OTHERS
9.9 SKIN SMOOTHENING
9.9.1 RESTYLANE
9.9.2 BELOTERO
9.9.3 BELLAFIL
9.9.4 OTHERS
9.1 DENTISTRY
9.10.1 JUVEDERM
9.10.2 RESTYLANE
9.10.3 RADIESSE
9.10.4 OTHERS
9.11 AESTHETIC RESTORATION
9.11.1 JUVEDERM
9.11.1.1 JUVEDERM ULTRA XC
9.11.1.2 JUVEDERM VOLLURE XC
9.11.1.3 JUVEDERM VOLBELLA XC
9.11.2 RESTYLANE
9.11.2.1 RESTYLANE-L
9.11.2.2 RESTYLANE SILK
9.11.2.3 RESTYLANE REFYNE AND DEFYNE
9.11.2.4 RESTYLANE LYFT
9.12 REVANESSE VERSA
9.13 SCULPTRA
9.14 RHA
9.14.1 RHA 2
9.14.2 RHA 3
9.14.3 RHA 4
9.15 BELLAFIL
9.16 BELOTERO BALANCE
9.17 OTHERS
9.18 LIP PLUM
9.18.1 RESTYLANE
9.18.2 BELOTERO
9.18.3 OTHERS
9.19 SCAR TREATMENT
9.19.1 JUVEDERM
9.19.2 RESTYLANE
9.19.3 RADIESSE
9.19.4 BELOTERO
9.19.5 PERLANE
9.19.6 OTHERS
9.19.6.1 KELOID SCARS
9.19.6.2 CONTRACTURE SCARS
9.19.6.3 HYPERTROPHIC SCARS
9.19.6.4 ACNE SCARS
9.19.6.5 OTHERS
9.2 CHIN AUGMENTATION
9.20.1 JUVEDERM VOLUMA XC
9.20.2 RESTYLANE
9.20.3 OTHERS
9.21 LIPOATROPHY TREATMENT
9.21.1 SCULPTRA
9.21.2 OTHERS
9.22 EARLOBE REJUVENATION
9.22.1 JUVEDERM
9.22.2 RESTYLANE
9.22.3 SCULPTRA
9.22.4 BELOTERO
9.22.5 ELLANSE
9.22.6 OTHERS
9.23 OTHERS
10 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.1.1 JUVÉDERM XC
10.2.1.2 JUVÉDERM ULTRA XC
10.2.1.3 JUVÉDERM ULTRA PLUS XC
10.2.1.4 JUVÉDERM VOLBELLA
10.2.1.5 JUVÉDERM VOLUMA
10.2.1.6 JUVÉDERM VOLLURE
10.2.2 RESTYLANE
10.2.2.1 RESTYLANE-L
10.2.2.2 RESTYLANE REFYNE
10.2.2.3 RESTYLANE DEFYNE
10.2.2.4 RESTYLANE LYFT
10.2.2.5 RESTYLANE SILK
10.2.2.6 RESTYLANE KYSSE
10.2.2.7 RESTYLANE CONTOUR
10.2.3 RADIESSE
10.2.4 SCULPTRA
10.2.5 ELLANSE
10.2.5.1 ELLANSE-S
10.2.5.2 ELLANSE-M
10.2.5.3 ELLANSE-L
10.2.5.4 ELLANSE-E
10.2.6 BELLAFILL
10.2.7 AQUAMID
10.2.8 OTHERS
10.3 GENERIC
11 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER
11.1 OVERVIEW
11.2 DERMATOLOGY CLINICS
11.3 HOSPITALS
11.4 AMBULATORY SURGICAL CENTERS
11.5 ACADEMIC RESEARCH INSTITUTES
11.6 OTHERS
12 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 DRUG STORES
12.4 RETAIL PHARMACY
12.5 ONLINE PHARMACY
12.6 OTHERS
13 NORTH AMERICA DERMAL FILLERS MARKET, BY GEOGRAPHY
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA DERMA FILLERS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 GALDERMA LABORATORIES, L.P
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 MERZ NORTH AMERICA, INC (A SUBSIDIARY OF MERZ PHARMA)
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE)
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 REVANCE THERAPEUTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AMALIAN
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ANIKA THERAPEUTICS, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BIOPLUS CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BIOXIS PHARMACEUTICALS
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CONTURA INTERNATIONAL LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CROMA-PHARMA GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 DSM
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FILLMED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 GIVAUDAN
16.14.1 COMPANY SNAPSHOT
16.14.2 RECENT FINANCIALS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 HUMEDIX (A SUBSIDIARY OF HUONS NORTH AMERICA)
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 IBSA FARMACEUTICI ITALIA SRL (A SUBSIDIARY OF IBSA INSTITUT BIOCHIMIQUE SA)
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IPSEN PHARMA.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 MEDYTROX
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 MESOESTETIC
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 PROLLENIUM MEDICAL TECHNOLOGIES
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SOSUM NORTH AMERICA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 SUNEVA MEDICAL
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 TEOXANE SA
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 ZIMMER AESTHETICS
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 COST OF DERMAL FILLERS
TABLE 2 COST OF PROCEDURE
TABLE 3 ASAPS PROCEDURE FACTS
TABLE 4 COMPENSATION COST FOR DERMAL FILLERS
TABLE 5 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 7 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 10 NORTH AMERICA NON-BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA MONOPHASIC FILLERS IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA FAT IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA COLLAGEN IN DERMAL FILLERS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 20 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA POLY-L-LACTIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA CALCIUM HYDROXYLAPATITE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA POLYALKYLIMIDE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 29 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 38 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 39 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA RHA IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 60 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 61 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 63 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 64 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 65 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 66 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 67 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 68 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 69 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 70 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 71 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 72 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 73 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 74 NORTH AMERICA ELLANSE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 75 NORTH AMERICA GENERIC IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 76 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 NORTH AMERICA DERMATOLOGY CLINICS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 78 NORTH AMERICA HOSPITALS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 79 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 80 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 81 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 82 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 NORTH AMERICA DIRECT TENDER IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 84 NORTH AMERICA DRUG STORES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 85 NORTH AMERICA RETAIL PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 86 NORTH AMERICA ONLINE PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 87 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DERMAL FILLERS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DERMAL FILLERS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DERMAL FILLERS MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DERMAL FILLERS MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DERMAL FILLERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA DERMAL FILLERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA DERMAL FILLERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA DERMAL FILLERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR ANTI-AGING DRUGS, AND GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES ARE EXPECTED TO DRIVE THE NORTH AMERICA DERMAL FILLERS MARKET IN THE FORECAST PERIOD 2022 TO 2029
FIGURE 12 BIODEGRADABLE DERMAL FILLER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DERMAL FILLERS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA DERMAL FILLERS MARKET
FIGURE 14 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, 2021
FIGURE 19 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2021
FIGURE 23 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA DERMAL FILLERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, 2021
FIGURE 27 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2021
FIGURE 31 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA DERMAL FILLERS MARKET: SNAPSHOT (2021)
FIGURE 39 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021)
FIGURE 40 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 41 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 42 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 43 NORTH AMERICA DERMA FILLERS MARKET: COMPANY SHARE 2021 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
